Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 510)
Posted On: 10/04/2022 3:23:28 PM
Post# of 153815
Posted By: Cassandra X
Long Haulers is not going away anytime soon. It is caused by other infectious diseases besides SARS2 and is a malfunction of the immune system. Many ME/CFS sufferers are testimony to this fact.

Leronlimab can reset the immune system like no other drug including, of course, Maraviroc. The sufferers of ME/CFS often cannot participate in the workforce and, thus, their contribution to the economic well being of us all is impacted. This must be recognized when calculating the benefit of Leronlimab to society and costs to the medical system.

Then, of course, the cost to society of all those suffering from other indications that can be treated by Leronlimab and the need for treatment of other diseases yet to evolve and you should begin to see why trials of Leronlimab to treat Long Haulers should continue.

I wouldn't count those trials out as time goes on. Reconsideration is always possible, especially if financing for trials becomes available.













(10)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site